Ezetimibe/rosuvastatin - AcheAlternative Names: rosuvastatin/ezetimibe - Ache
Latest Information Update: 10 Nov 2016
At a glance
- Originator Ache Laboratories
- Class Antihyperlipidaemics; Azetidines; Fluorobenzenes; Propanols; Pyrimidines; Small molecules; Sulfonamides
- Mechanism of Action Cholesterol absorption inhibitors; HMG-CoA reductase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase III Dyslipidaemias; Hypercholesterolaemia